In this issue:
Molecular mechanisms mediating risk factors & MS onset
Anti-BCMA CAR T-cell therapy in PMS
MS-STAT2: simvastatin in SPMS
B-cell repopulation dynamics with memory B-cell-guided extended interval ocrelizumab dosing
ASCEND/SPECTRIMS: disability progression in SPMS with natalizumab vs. interferon β-1a
EBV infection in children with MS
Risk factors for ED visits in MS
Fish consumption & MS progression
Autoimmune comorbidities in MS
CSF molecular diagnostic tests in real-world MS patients
Please login below to download this issue (PDF)